This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Instytut Biochemii I Biofizyki Polskiej Akademii Nauk, Instytut Immunolii I Terapii Doswiadczalnej Polskiej Akademii Nauk, Narodowy Instytut Lekow. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1 
1 out of 4 Years Active: 2017
Title: Romuald Gryko: Innovator in Bacteriophage Therapeutics
Introduction
Romuald Gryko is a notable inventor based in Pulawy, Poland. He has made significant contributions to the field of bacteriophage therapy, particularly in evaluating the therapeutic efficacy of these preparations. His innovative approach has the potential to impact the treatment of infections caused by pathogenic bacteria in both humans and animals.
Latest Patents
Romuald Gryko holds a patent for a method of evaluating the therapeutic efficacy of bacteriophages. This patent introduces a novel use of a nematode in assessing the effectiveness of bacteriophage preparations. The invention aims to enhance the treatment options available for bacterial infections, showcasing Gryko's commitment to advancing medical science.
Career Highlights
Throughout his career, Romuald Gryko has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Romuald Gryko has collaborated with notable colleagues, including Malgorzata Lobocka and Aleksandra Glowacka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Romuald Gryko's contributions to bacteriophage therapy and his innovative patent demonstrate his dedication to improving medical treatments. His work continues to inspire advancements in the field of infectious disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile